Identification of genetic variants in Pfs25 and functional evaluation in mosquito infection
Authors:
- Alessandra OrfanoAOAlessandra Orfano
- Awa CisseACAwa Cisse
- Yicheng GuoYGYicheng Guo
- Leeah HanLHLeeah Han
- Nathan FikaduNFNathan Fikadu
- Laty G. ThiamLTLaty G. Thiam
- Aboubacar BaABAboubacar Ba
- Rebecca LiRLRebecca Li
- Mariama N. PouyeMPMariama N. Pouye
- Khadidiatou MangouKMKhadidiatou Mangou
- Adam J. MooreAMAdam J. Moore
Preprint
Abstract
Transmission-blocking vaccines (TBVs) are a promising strategy to reduce malaria transmission by targeting parasite stages within the mosquito. However, parasite genetic diversity may limit vaccine efficacy. We used next-generation amplicon deep sequencing to identify non-synonymous single nucleotide polymorphisms (SNPs) in Pfs25 from 184 Plasmodium falciparum isolates from Senegal, Tanzania, Ghana, and Burkina Faso. Prioritized SNPs were introduced into P. falciparum via CRISPR-Cas9. For the G116C variant, gametocyte development was evaluated by microscopy and qPCR, and mosquito infectivity was assessed by SMFAs. We identified 26 SNPs, including 24 novel variants. Functional assays showed that the Pfs25 G116C mutation did not affect gametocyte development or exflagellation. SMFA showed no significant differences in oocyst prevalence or intensity between mutant and WT parasites. These findings highlight the importance of integrating genetic surveillance with functional validation to guide the development of effective transmission blocking interventions.Keywords
Funding Information
- Fulbright Program
This publication has 79 references indexed in Scilit:
- Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparumEBioMedicine, 2024
- Leveraging genome editing to functionally evaluate Plasmodium diversityTrends in Parasitology, 2022
- Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsVaccine, 2018
- Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidateAnalytical Biochemistry, 2018
- Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trialThe Lancet, 2015
- Malaria transmission dynamics of the Anopheles mosquito in Kumasi, GhanaInternational Journal of Infectious Diseases, 2014
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticleVaccine, 2013
- How do malaria ookinetes cross the mosquito midgut wall?Trends in Parasitology, 2005
- Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, internet access and reviewTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999